What infections actually need beta-lactamase coverage vs can skip it?

The short version: you need beta-lactamase coverage only when the infection site or local resistance patterns make a beta-lactamase producer likely. For most common infections in otherwise healthy people, plain amoxicillin is enough.

The clavulanate in Augmentin blocks the enzyme that some bacteria use to destroy amoxicillin. The question is which infections actually need that extra help. The evidence here is mostly about ear infections in children, with some data on pneumonia and surgical prophylaxis.

Infections where beta-lactamase coverage is needed. Acute otitis media in children who have recently failed amoxicillin. A 1991 study found beta-lactamase-producing bacteria were common in treatment-failure cases [1]. Moraxella catarrhalis, a common ear infection bug, produces beta-lactamase in about 75% of isolates [2]. Haemophilus influenzae produces it in about 17% of isolates [7]. For children with recurrent or persistent otitis media, Augmentin is the standard choice. Bite wounds, diabetic foot infections, and breast abscesses all involve mixed bacteria including anaerobes and beta-lactamase producers, as covered in the previous answer.

Infections where plain amoxicillin is sufficient. For community-acquired pneumonia in adults, a 2004 trial found standard-dose Augmentin (875/125 mg) worked as well as a higher-dose version, meaning the beta-lactamase coverage was not the limiting factor [4]. For surgical prophylaxis in clean-contaminated head and neck surgery, Augmentin was no better than cefazolin alone [3]. For laparoscopic gynecologic surgery, both drugs worked equally well [5]. In children with acute otitis media, a 2006 Turkish study found amoxicillin-clavulanate had higher cure rates for H. influenzae (100% vs 75%) but overall efficacy was similar between Augmentin and azithromycin [7]. The 2023 systematic review confirmed Augmentin was superior to older drugs like cefaclor and penicillin, but that comparison is against drugs that also lack beta-lactamase coverage [8].

The real question is local resistance patterns. In the Turkish study, 55% of M. catarrhalis and 17% of H. influenzae produced beta-lactamase [7]. In the 2004 pneumonia trial, beta-lactamase production was found in about half of H. influenzae and most M. catarrhalis isolates [4]. These numbers vary by region and over time. Without knowing your local resistance rates, you are guessing.

My call: For a first episode of otitis media or uncomplicated pneumonia in a healthy person, plain amoxicillin is fine. Beta-lactamase coverage is needed only for recurrent ear infections, bite wounds, diabetic foot infections, and infections where local resistance rates are known to be high. Confidence: moderate. The evidence is mostly from ear infection studies in children and pneumonia trials in adults, with limited data on other common infections.